Switzerland
As a Pharm.D. - Ph.D., I always have been attracted by therapeutic innovation. I was able to put this in practice a a project team leader for a high-throughput, high-content phenotypic screening campaign in triple negative breast cancer. Joining a venture capital firm after that enabled me to understand the metrics behind a successful entrepreneurial endeavor. Today, still driven by the desire to improve patient survival in oncology, being an Investment Director at Cumulus enables me to shape our pipeline by selecting innovative solutions to be develop through the clinic.
Medical device company that designs and manufactures catheter-based systems for the treatment of supra-ventricular tachycardias.
First-in-class endocannabinoid modulators to restore natural functioning of the brain in CNS disorders.